180 related articles for article (PubMed ID: 20350868)
1. [Host defense peptides and peptidomimetics as new weapons for cancer treatment].
Lapis K
Magy Onkol; 2010 Mar; 54(1):47-58. PubMed ID: 20350868
[TBL] [Abstract][Full Text] [Related]
2. Cationic amphiphilic peptides with cancer-selective toxicity.
Schweizer F
Eur J Pharmacol; 2009 Dec; 625(1-3):190-4. PubMed ID: 19835863
[TBL] [Abstract][Full Text] [Related]
3. Potential therapeutic application of host defense peptides.
Zhang L; Falla TJ
Methods Mol Biol; 2010; 618():303-27. PubMed ID: 20094872
[TBL] [Abstract][Full Text] [Related]
4. Host defense peptides as new weapons in cancer treatment.
Papo N; Shai Y
Cell Mol Life Sci; 2005 Apr; 62(7-8):784-90. PubMed ID: 15868403
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial peptides.
Izadpanah A; Gallo RL
J Am Acad Dermatol; 2005 Mar; 52(3 Pt 1):381-90; quiz 391-2. PubMed ID: 15761415
[TBL] [Abstract][Full Text] [Related]
6. Applications of antimicrobial peptides from fish and perspectives for the future.
Rajanbabu V; Chen JY
Peptides; 2011 Feb; 32(2):415-20. PubMed ID: 21093512
[TBL] [Abstract][Full Text] [Related]
7. Anticancer Drug Development: The Way Forward.
Connors T
Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
[TBL] [Abstract][Full Text] [Related]
8. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
9. Using antimicrobial host defense peptides as anti-infective and immunomodulatory agents.
Kruse T; Kristensen HH
Expert Rev Anti Infect Ther; 2008 Dec; 6(6):887-95. PubMed ID: 19053901
[TBL] [Abstract][Full Text] [Related]
10. New lytic peptides based on the D,L-amphipathic helix motif preferentially kill tumor cells compared to normal cells.
Papo N; Shai Y
Biochemistry; 2003 Aug; 42(31):9346-54. PubMed ID: 12899621
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation and consideration of BRM-BRM and HDP (host defense potentiators)].
Chihara G
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-3):1588-96. PubMed ID: 3382231
[TBL] [Abstract][Full Text] [Related]
12. Peptide-based cancer therapy: opportunity and challenge.
Wu D; Gao Y; Qi Y; Chen L; Ma Y; Li Y
Cancer Lett; 2014 Aug; 351(1):13-22. PubMed ID: 24836189
[TBL] [Abstract][Full Text] [Related]
13. Sensitization of human bladder cancer cells to Fas-mediated cytotoxicity by cis-diamminedichloroplatinum (II).
Mizutani Y; Yoshida O; Bonavida B
J Urol; 1998 Aug; 160(2):561-70. PubMed ID: 9679929
[TBL] [Abstract][Full Text] [Related]
14. REIC/Dkk-3 overexpression downregulates P-glycoprotein in multidrug-resistant MCF7/ADR cells and induces apoptosis in breast cancer.
Kawasaki K; Watanabe M; Sakaguchi M; Ogasawara Y; Ochiai K; Nasu Y; Doihara H; Kashiwakura Y; Huh NH; Kumon H; Date H
Cancer Gene Ther; 2009 Jan; 16(1):65-72. PubMed ID: 18654608
[TBL] [Abstract][Full Text] [Related]
15. Role of host defense peptides of the innate immune response in sepsis.
Hirsch T; Metzig M; Niederbichler A; Steinau HU; Eriksson E; Steinstraesser L
Shock; 2008 Aug; 30(2):117-26. PubMed ID: 18091568
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of P-glycoprotein function by XR9576 in a solid tumour model can restore anticancer drug efficacy.
Walker J; Martin C; Callaghan R
Eur J Cancer; 2004 Mar; 40(4):594-605. PubMed ID: 14962729
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of chemotherapeutic drug resistance in cancer therapy--a quick review.
Liu FS
Taiwan J Obstet Gynecol; 2009 Sep; 48(3):239-44. PubMed ID: 19797012
[TBL] [Abstract][Full Text] [Related]
18. Novel mode of action of polybia-MPI, a novel antimicrobial peptide, in multi-drug resistant leukemic cells.
Wang KR; Yan JX; Zhang BZ; Song JJ; Jia PF; Wang R
Cancer Lett; 2009 Jun; 278(1):65-72. PubMed ID: 19233550
[TBL] [Abstract][Full Text] [Related]
19. [Bases on timing of combined modality of chemotherapy and immunotherapy].
Ogura T
Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 1):1414-20. PubMed ID: 1697153
[TBL] [Abstract][Full Text] [Related]
20. Antitumor activity of the antimicrobial peptide magainin II against bladder cancer cell lines.
Lehmann J; Retz M; Sidhu SS; Suttmann H; Sell M; Paulsen F; Harder J; Unteregger G; Stöckle M
Eur Urol; 2006 Jul; 50(1):141-7. PubMed ID: 16476519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
